Adaptive Biotechnologies' COO Sells Over 19,000 Shares in April 2026
Adaptive Biotechnologies' Chief Operating Officer, Julie Rubinstein, sold 19,037 shares of the company's stock on April 27, 2026, for approximately $271,000. The transaction represented 4.8% of her direct holdings and was linked to the exercise of 14,707 stock options. The sale may signal insider activity but does not necessarily indicate a negative outlook on the company's stock.
Tickers: $ADPT
Topics: corporate_governance executive_stock_sales SEC_filings